GoHealth (NASDAQ:GOCO) Shares Down 3.3% – Should You Sell?
by Scott Moore · The Cerbat GemGoHealth, Inc. (NASDAQ:GOCO – Get Free Report) dropped 3.3% during mid-day trading on Thursday . The stock traded as low as $1.3950 and last traded at $1.48. Approximately 40,471 shares traded hands during trading, a decline of 49% from the average daily volume of 78,643 shares. The stock had previously closed at $1.53.
Analyst Upgrades and Downgrades
GOCO has been the topic of a number of research analyst reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of GoHealth in a report on Monday, December 29th. Royal Bank Of Canada reduced their price objective on GoHealth from $12.00 to $5.00 and set a “sector perform” rating on the stock in a research note on Wednesday, November 26th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $5.00.
Read Our Latest Stock Report on GoHealth
GoHealth Trading Up 2.7%
The stock has a market capitalization of $43.65 million, a PE ratio of -0.10 and a beta of 1.70. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 2.64. The business’s 50-day moving average is $1.90 and its two-hundred day moving average is $3.02.
Institutional Investors Weigh In On GoHealth
Large investors have recently modified their holdings of the stock. Public Sector Pension Investment Board acquired a new position in GoHealth during the 3rd quarter worth approximately $8,100,000. Redwood Capital Management LLC acquired a new stake in GoHealth in the third quarter valued at approximately $4,455,000. Geode Capital Management LLC raised its stake in shares of GoHealth by 8.1% during the fourth quarter. Geode Capital Management LLC now owns 150,821 shares of the company’s stock valued at $324,000 after purchasing an additional 11,340 shares during the period. Corient Private Wealth LLC raised its stake in shares of GoHealth by 7.7% during the second quarter. Corient Private Wealth LLC now owns 125,938 shares of the company’s stock valued at $699,000 after purchasing an additional 8,979 shares during the period. Finally, Barclays PLC lifted its position in shares of GoHealth by 10.1% during the fourth quarter. Barclays PLC now owns 81,181 shares of the company’s stock worth $175,000 after purchasing an additional 7,430 shares in the last quarter. Institutional investors and hedge funds own 24.21% of the company’s stock.
About GoHealth
GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.
The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.